SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-17-012750
Filing Date
2017-02-21
Accepted
2017-02-21 16:45:17
Documents
2
Period of Report
2017-02-16

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 11105
2 EX-24 DOCUMENT attachment1.htm EX-24 3235
  Complete submission text file 0001209191-17-012750.txt   15892
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Issuer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 30 ROCKEFELLER PLAZA, SUITE 5508 NEW YORK NY 10112
Business Address
Hove Anders D (Reporting) CIK: 0001365618 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-22873 | Film No.: 17625635